Inventor · disambiguated record
Moshe Talpaz
Also filed as: TALPAZ MOSHE
9 granted patents·5 pending applications·18 citations·filing 2002–2014
83Inventor score
Top patents by PatentIndex Score
14 records- 0181US7745468B2Compounds for treatment of cell proliferative diseasesUNIV TEXAS·Filed 2004·Granted Jun 29, 2010·12 cites·23 claims
- 0280US8119649B2Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemiaDONATO NICHOLAS J·Filed 2009·Granted Feb 21, 2012·1 cites·6 claims
- 0372US9096499B2Compounds for treatment of cell proliferative diseasesUNIV TEXAS·Filed 2014·Granted Aug 4, 2015·1 cites·10 claims
- 0471US9868736B2Deubiquitinase inhibitors and methods for use of the sameUNIV MICHIGAN REGENTS·Filed 2014·Granted Jan 16, 2018·1 cites·22 claims
- 0571US8648102B2Compounds for treatment of cell proliferative diseasesPRIEBE WALDEMAR·Filed 2012·Granted Feb 11, 2014·1 cites·12 claims
- 0671US8119827B2Compounds for treatment of cell proliferative diseasesPRIEBE WALDEMAR·Filed 2010·Granted Feb 21, 2012·1 cites·16 claims
- 0768US2007149539A1Use of c-src inhibitors alone or in combination with sti571 for the treatment of leukaemiaDONATO NICHOLAS J·Filed 2007·Application pending·0 cites
- 0864US8809377B2Deubiquitinase inhibitors and methods for use of the sameDONATO NICHOLAS J·Filed 2011·Granted Aug 19, 2014·1 cites·22 claims
- 0964US8268837B2Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemiaDONATO NICHOLAS J·Filed 2005·Granted Sep 18, 2012·0 cites·1 claims
- 1059US2004248906A1Use of c-src inhibitors alone or in combination with st1571 for the treatment of leukaemiaFiled 2002·Application pending·0 cites
- 1157US2007027167A1Use of c-Src inhibitors alone or in combinaton with STI571 for the treatment of leukaemiaDONATO NICHOLAS J·Filed 2006·Application pending·0 cites
- 1250US2014357673A1Deubiquitinase Inhibitors and Methods for Use of the SameUNIV MICHIGAN·Filed 2014·Application pending·0 cites
- 1340US2010292229A1Tryphostin-analogs for the treatment of cell proliferative diseasesUNIV TEXAS·Filed 2007·Application pending·0 cites
- 1435US7468379B2Inhibition of osteolytic lesions by SRC kinase inhibitorsUNIV TEXAS·Filed 2006·Granted Dec 23, 2008·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Moshe Talpaz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →